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Summary 17"
Herpes simplex virus 1 (HSV1) infects humans through stratified epithelia that are 18"
composed primarily of keratinocytes. The route of HSV1 entry into keratinocytes has been 19"
the subject of limited investigation, but is proposed to involve pH-dependent endocytosis, 20"
requiring the gD-binding receptor, nectin-1. Here, we have utilized the nTERT human 21"
keratinocyte cell line as a new model for dissecting the mechanism of HSV1 entry in to the 22"
host. Although immortalised, these cells nonetheless retain normal growth and 23"
differentiation properties of primary cells. Using siRNA depletion studies, we confirm that, 24"
despite nTERT cells expressing high levels of the alternative gD receptor HVEM, HSV1 25"
requires nectin-1, not HVEM, to enter these cells. Strikingly, virus entry into nTERT cells 26"
occured with unusual rapidity, such that maximum penetration was achieved within 5 27"
minutes. Moreover, HSV1 was able to enter keratinocytes but not other cell types at 28"
temperatures as low as 7°C, conditions where endocytosis was shown to be completely 29"
inhibited. Transmission electron microscopy of early entry events at both 37°C and 7°C 30"
identified numerous examples of naked virus capsids located immediately beneath the 31"
plasma membrane, with no evidence of virions in cytoplasmic vesicles. Taken together, 32"
these results imply that HSV1 uses the nectin-1 receptor to enter human keratinocyte cells 33"
via a previously uncharacterised rapid plasma membrane fusion pathway that functions at 34"
low temperature. These studies have important implications for current understanding of 35"
the relationship between HSV1 and its relevant in vivo target cell. 36"
 37"
  38"
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Importance  39"
The gold standard of antiviral treatment for any human virus infection is the prevention of 40"
virus entry into the host cell. In the case of HSV1, primary infection in the human begins in 41"
the epidermis of the skin or the oral mucosa, where the virus infects keratinocytes, and it is 42"
therefore important to understand the molecular events involved in HSV1 entry into this 43"
cell type. Nonetheless, few studies have looked specifically at entry into these relevant 44"
human cells. Our results reveal a new route for virus entry that is specific to keratinocytes, 45"
involves rapid entry, and functions at low temperatures. This may reflect the environmental 46"
conditions encountered by HSV1 when entering its host through the skin and emphasizes 47"
the importance of studying virus-host interactions in physiologically relevant cells.  48"
 49"
 50"
  51"
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Introduction 52"
Herpes simplex virus type 1 (HSV1) gains access to its human host through the epidermis 53"
at the oral mucosa, skin or the cornea, where the majority of the cells are keratinocytes. 54"
Hence, although HSV1 replication has been studied in many cell types in vitro, the role of 55"
the human keratinocyte in the HSV1 life cycle makes it the most physiologically relevant 56"
cell type in which to unravel HSV1 replication strategies important in its natural host.  To 57"
date, there have been only a few studies on the mechanism of HSV1 entry into human 58"
keratinocytes. While initial studies on other cell types indicated that HSV1 enters cells by 59"
fusion at the plasma membrane following virion attachment to the cell surface receptor (1, 60"
2), it has now become widely accepted that in keratinocytes as well as certain other cell 61"
types, the virus particle undergoes endocytosis before fusing with the endocytic 62"
membrane internally in the cytoplasm in a pH-dependent fashion (3-6). Crucially, an 63"
immunofluorescence study in the HaCaT keratinocyte cell line found that virions 64"
colocalised with a marker of fluid phase endocytosis (3). Other studies, including the use 65"
of the inhibitor of endocytosis dynasore and overexpression of a dominant-negative 66"
dynamin has shown that the virus may enter keratinocytes by both endocytosis and 67"
plasma membrane fusion (7), suggesting that unusually the virus may exploit alternative 68"
pathways in this single cell type. To add to the complexity of HSV1 entry, it has been 69"
reported that despite being receptor dependent, HSV1 endocytosis does not use either 70"
clathrin or caveolin mediated entry in a range of epithelial cells (8, 9), and can occur in a 71"
pH independent fashion (4), features that may be more indicative of macropinocytosis 72"
entry rather than receptor-mediated endocytosis.  73"
HSV1 is believed to bind keratinocytes through the HveC gD receptor, more commonly 74"
known as the adhesion molecule nectin-1 (3, 10). Nectin-1 is expressed in both 75"
keratinocytes and neurons (10), and has previously been shown to be highly expressed in 76"
the HaCaT keratinocyte cell line (11). Moreover, knockout of nectin-1 from murine 77"
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keratinocytes greatly reduced HSV1 entry (12). A second gD receptor, HVEM (HveA), the 78"
first HSV1 receptor identified in a seminal study by Montgomery and coworkers (13), is a 79"
member of the tumour necrosis factor receptor family (13), which despite being originally 80"
isolated from a HeLa cell cDNA library, has been shown to be expressed predominantly on 81"
lymphoid cells (14). Furthermore, studies on cultured murine keratinocytes have shown 82"
that HVEM is absent from these cells (12). Like HVEM, another potential receptor for 83"
HSV1 in the form of the gB receptor paired immunoglobulin-like type 2 receptor 84"
PILRα (15), has also been shown to be expressed predominantly on cells of the immune 85"
system (15, 16).   86"
In the study presented here, we have utilised the human nTERT keratinocyte cell line as a 87"
model system for studying HSV1 entry. The nTERT line is derived from primary human 88"
keratinocytes which have been retrovirally induced to express hTERT, the catalytic subunit 89"
of the telomerase holoenzyme, and subsequently have spontaneously lost the function of 90"
p16INK4a, a tumour suppressor gene which usually inhibits the transition from G1 to S 91"
phase.  This allows the maintenance of growth for much longer than normal primary cell 92"
types (17). Crucially, nTERT cells are still dependent on epidermal growth factor, are able 93"
to differentiate, and remain non-invasive upon transplantation, indicating that they retain 94"
many characteristics of primary cells. Moreover they have been used as a successful 95"
model system for other epitheliotropic viruses such as varicella zoster virus and human 96"
papilloma virus (18, 19), suggesting they are an appropriate system to study HSV1 97"
infection of relevant human cells. 98"
In this report we show that HSV1 enters nTERT cells through nectin-1 binding, despite 99"
high expression levels of the HVEM receptor. In contrast to other studies, our results show 100"
that HSV1 entry into human keratinocytes occurs only via a direct plasma membrane 101"
fusion mechanism. Moreover, infection is initiated rapidly in keratinocytes, with maximal 102"
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penetration occurring in just 5 minutes.  Unexpectedly, virus penetration in keratinocyte 103"
cells was also shown to extend to temperatures as low as 7°C, an event confirmed at the 104"
ultrastructural level. Hence, we suggest that HSV1 has a specific entry route into human 105"
keratinocytes that favours the potential environmental conditions that the virus encounters 106"
when infecting its human host.   107"
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Materials and Methods 108"
Cells and Viruses. Vero and HeLa cells were cultured in DMEM supplemented with 10% 109"
newborn calf serum (NCS). HaCaT and HFFF2 cells were grown in DMEM media 110"
supplemented with 10% v/v foetal bovine serum (FBS).  nTERT keratinocyte cells (17) 111"
were grown in cells maintained in 3:1 DMEM:Ham's F12 supplemented with 10% FBS, 10 112"
ng/ml mouse epidermal growth factor (Serotec), 1 ng/ml cholera toxin (Sigma), 400 ng/ml 113"
hydrocortisone (Sigma), 5 mg/ml insulin (Sigma), 5 mg/ml transferrin (Sigma), 13 ng/ml 114"
liothyronine (Sigma) and 2mM L-Glutamine (Invitrogen).  HSV1 strain s17 was routinely 115"
propagated and titrated in Vero cells in DMEM supplemented with 2% serum. HSV1 strain 116"
sc16 expressing β−galactosidase under the control of the ICP0 promoter inserted into the 117"
non-essential US5 locus (110lacZ) was kindly provided by Prof Stacey Efstathiou, 118"
University of Cambridge (20). For transmission electron microscopy studies, released 119"
HSV1 virions were gradient purified as described previously (21). 120"
Antibodies. Monoclonal anti-ICP27 and anti-gD were kindly provided by Steve Rice 121"
(University of Minnesota) and Tony Minson (University of Cambridge), respectively. 122"
Polyclonal anti-VP22 has been described before (22), while monoclonal anti-ICP0 (11060) 123"
and anti-α tubulin were purchased from Santa-Cruz and Sigma respectively.  124"
Adsorption Assay. One-day-old confluent monolayers of cells in 6-well plates were pre-125"
chilled on ice for 15 mins.  Cell culture media was removed and replaced with 200 plaque 126"
forming units (pfu) of virus diluted in 500 µl of ice-cold infection media. To allow virus to 127"
bind but not enter cells, the cells were incubated on ice for the times specified in the Fig. 128"
legends, then washed twice with ice-cold PBS.   Cells were then overlaid with fresh, warm, 129"
media containing 1% human serum and returned to 37°C for 2 days.  Cells were fixed and 130"
stained with 0.1% crystal violet before plaques were counted.  131"
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Penetration Assay. One-day-old confluent monolayers of cells in 6-well plates were pre-132"
chilled on ice for 15 min. Cell culture media was removed and replaced with 200 pfu of 133"
virus diluted in 500 µl of ice-cold infection media. Cells were incubated for 1 hour on ice, 134"
before washing with pre-warmed/chilled media (without virus) and incubating at the 135"
temperatures stated. After each indicated length of time, cells were placed on ice and 136"
treated with 500 µl of ice-cold pH 3 citrate buffer (23) for 1 min to inactivate bound virus, 137"
before being washed twice with ice-cold PBS.  Cells were then overlaid with fresh, warm, 138"
media containing 1% human serum and returned to 37°C for 2 days.  Cells were fixed and 139"
stained with 0.1% crystal violet before plaques were counted. 140"
siRNAs and Transfection. Two Silencer Select, nectin-1-specific siRNAs were purchased 141"
from Thermo Fisher (PVRL1: s11604 and s11605); pooled siRNAs to HVEM were 142"
purchased from Insight Biotechnology. siRNAs were transfected with Lipofectamine 2000 143"
(Invitrogen) according to the manufacturer’s instructions for reverse transfection.  The final 144"
concentration of siRNA was 30 nM per set.  The Silencer Select negative siRNA number 1 145"
(Ambion) was used as a negative control. 146"
qRT-PCR. Total RNA was extracted from cells using Qiagen RNeasy kit. Excess DNA was 147"
removed from RNA by diluting 1 µg of RNA in 8 µl nuclease-free water (Ambion) followed 148"
by the addition of 1 µl 10X DNase reaction buffer (Invitrogen) and 1 µl amplification grade 149"
DNase I (1 U/µl, Invitrogen) and incubating for 15 mins at room temperature. DNase was 150"
inactivated by a 10 min incubation at 65°C in 25 nM of EDTA.  Superscript III™ 151"
(Invitrogen) was used to make cDNA according to manufacturers instructions using 152"
random primers. All qRT-PCR assays were carried out in 96 well plates using MESA Blue 153"
qPCR MasterMix Plus for SYBR® Assay (Eurogentec), using forward and reverse primers 154"
for the housekeeping gene RPLP0 (F-actctgcattctcgcttcct; R-ggactcgtttgtacccgttg); nectin-1 155"
(F-ctgcaaagctgatgctaacc; R-gatgggtcccttgaagaaga) and HVEM (Stratech Scientific Ltd). 156"
REVISED MANUSCRIPT 
 9 
Cycling was carried out on a QuantStudio 7 qPCR machine (Applied Biosystems). Relative 157"
expression of each receptor was determined using the ΔΔct method (24), using the 158"
housekeeping gene RPLP0 as the reference gene. 159"
β-Galactosidase Quantification. Confluent layers of cells, seeded in 96 well plates, were 160"
infected with sc16110lacZ virus at a multiplicity of 2 for one hour on ice.  The inoculum 161"
was then removed and replaced with fresh, pre-warmed media and the cells were 162"
incubated for 4 hours at 37°C.  The media was removed by aspiration and the cells were 163"
washed twice with ice cold PBS, before being lysed and analysed using the Invitrogen β-164"
Gal Assay Kit.  Standards were prepared with β-galactosidase (β-gal) enzyme (Sigma) and 165"
absorbance at 420 nm was read on a FLUOstar Omega multimode microplate reader 166"
(BMG Labtech, Offenburg, Germany). β-gal activity was calculated from the standard 167"
curve, as mU β-galactosidase activity per well. 168"
Transmission Electron Microscopy.  Cells for TEM were fixed in 0.5% glutaraldehyde in 169"
200mM sodium cacodylate buffer for 30min, washed in buffer and secondarily fixed in 170"
reduced 1% osmium tetroxide, 1.5% potassium ferricyanide for 60 min. The samples were 171"
washed in distilled water and stained overnight at 4ºC in 0.5% magnesium uranyl acetate, 172"
washed in distilled water and dehydrated in graded ethanol. The samples were then 173"
embedded flat in the dish in Epon resin. Resin filled stubs were placed on embedded cell 174"
monolayers and polymerized. Ultrathin sections (typically 50 to 70 nm) were cut parallel or 175"
perpendicular to the dish and examined in a FEI Tecnai electron microscope with CCD 176"
camera image acquisition.  177"
SDS-PAGE and Western Blotting. Protein samples were analysed on 10% 178"
polyacrylamide gels and subjected to electrophoresis in Tris-glycine buffer. Gels were 179"
transferred to nitrocellulose membrane for Western blot analysis. Western blots were 180"
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developed using SuperSignal® West Pico chemiluminescent substrate (Thermo Fisher 181"
Scientific).  182"
Transferrin Uptake Assay and Immunofluorescence. One-day old cells seeded on 13 183"
mm cover slips were pre-incubated at various temperatures for 15 minutes before being 184"
washed once with DMEM without serum. Texas Red® conjugated transferrin (Invitrogen, 185"
2.5 µg/ml) in DMEM without serum was then added to cells and incubated at various 186"
temperatures for 30 mins before washing and fixing with 4% paraformaldehyde in PBS for 187"
20 min followed by permeabilisation with 0.5% triton-X100 for 10 min. The coverslips were 188"
then washed extensively in PBS and mounted in Vectashield containing DAPI (Vector 189"
Labs). Images were acquired using a x63 objective on a Zeiss LSM510 Meta confocal 190"
microscope, and processed using Adobe Photoshop software.  191"
 192"
 193"
  194"
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RESULTS 195"
HSV1 replicates with faster kinetics in nTERT keratinocytes than Vero cells. The 196"
nTERT cell line has previously been used for studies on human papilloma virus and 197"
varicella zoster virus (18, 19). However, at the beginning of this study the efficiency of 198"
HSV1 to infect and replicate in these cells was unknown. To establish whether nTERT 199"
cells were permissive to HSV1 infection, these cells were assessed for their ability to 200"
support virus replication in a one-step growth curve. Monolayers of nTERT cells were 201"
infected with HSV1 (strain 17) at a multiplicity of 2 and extracellular and cell-associated 202"
virus harvested at the indicated times (Fig. 1A).  Progeny virus was first detected at 8 h 203"
and increased steadily until 16 h when production plateaued (Fig. 1A). The level of 204"
extracellular virus indicated that virus was released efficiently, demonstrating that HSV1 205"
can enter and maintain a classical replication cycle in these cells. Interestingly, 206"
comparison of HSV1 one-step growth kinetics in nTERT and Vero cells indicated that 207"
progeny virus is produced around 4 hours earlier from the nTERT monolayer (Fig. 1B). 208"
To determine if earlier production of progeny virus is related to earlier or greater virus 209"
protein synthesis, samples of infected Vero and nTERT cells were harvested at 210"
representative times up to 8 hours after infection, and analysed by Western blotting for two 211"
immediate- early proteins (ICP0 and ICP27), and two late proteins (VP22 and gD) using α-212"
tubulin as a loading control (Fig. 1C). All virus proteins tested were detected 2 hours 213"
earlier in nTERT than Vero cells, with the immediate early proteins readily detected at just 214"
2 hours after infection (Fig. 1C). Nonetheless, maximum levels of viral protein expression 215"
in nTERT cells were only slightly enhanced compared to Vero cells. This earlier 216"
expression of immediate-early proteins was confirmed by staining cells for ICP0. Counting 217"
of ICP0 positive cells in three independent experiments indicated that ICP0 was 218"
consistently detectable in over 50% of nTERT cells as early as one hour after infection 219"
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(Fig. 1D).  By contrast, only around 15% of Vero cells were positive for ICP0 at this time, 220"
and it took another 4 hours for the proportion of ICP0 positive Vero cells to catch up with 221"
nTERT cells. Moreover, titration of our stock virus on Vero and nTERT cells indicated that 222"
there was no significant difference in the plaquing efficiency of HSV1 on these two cell 223"
lines that could explain the faster onset of virus infection in the keratinocyte cells (data not 224"
shown). Taken together these results suggest that virus protein expression is induced 225"
more rapidly in nTERT cells than Vero cells after infection with the same multiplicity of 226"
virus. 227"
HSV1 enters nTERT keratinocyte cells via the nectin-1 receptor. Because other 228"
studies have indicated nectin-1 as the major receptor used for HSV1 entry into 229"
keratinocytes (3, 10) and nectin-1 has previously been shown to be highly expressed in 230"
the human HaCaT keratinocyte cell line (11), we next quantified the level of nectin-1 and 231"
HVEM mRNA in both nTERT cells and HeLa cells, the cell type from which both receptors 232"
had first been identified (10, 13, 25). As a further control for HVEM mRNA, we included the 233"
human THP-1 line where HVEM should be highly expressed (13). Using qRT-PCR, nectin-234"
1 was found to be expressed close to 70-fold higher in nTERT cells compared to HeLa 235"
cells and THP-1 monocytes (Fig. 2A). Surprisingly, despite HVEM having been originally 236"
identified from a HeLa cell cDNA library (13), HVEM mRNA was barely detectable in our 237"
HeLa cells by qRT-PCR, using conditions where it was detectable in other cell types (Fig. 238"
2B). Moreover, HVEM mRNA was unexpectedly detected in nTERTs, at levels around 239"
600-fold higher than HeLa and 8-fold higher than in monocytes (Fig. 2B). This raised the 240"
possibility of either or both of these receptors being involved in entry into keratinocytes, so 241"
we next depleted each receptor from both HeLa nTERT cells using siRNAs specific for 242"
each. Depletion was shown to be successful in both cell types by qRT-PCR of RNA 243"
harvested 48 hours after transfection (Fig. 2C). Sixty hours after transfection, cells were 244"
REVISED MANUSCRIPT 
 13 
infected with a virus expressing β-gal under the control of the IE110 promoter and 245"
harvested 5 h later for quantification of β-gal activity, which was used as an indirect 246"
measure of virus entry (Fig. 2D). The results show that depletion of nectin-1 from both 247"
HeLa and nTERT cells reduced β-gal activity to around 10% of that present in cells 248"
transfected with negative siRNA, correlating with the relative depletion of the mRNA for 249"
this receptor (Fig. 2D). By contrast, depletion of HVEM had no significant effect on entry 250"
into either nTERT cells or HeLa cells (Fig. 2D). Therefore, we conclude that HSV1 enters 251"
both nTERT and HeLa cells primarily via the nectin-1 receptor. To our knowledge, this is 252"
the first direct demonstration of a requirement for nectin-1 in HSV1 entry into HeLa cells. 253"
HSV1 enters nTERT cells with unusual rapidity. To test the efficiency of HSV1 binding 254"
to nTERT cells in comparison to Vero cells, the rate of virus binding was measured using 255"
an adapted form of an adsorption assay (26).  Monolayers of Vero or nTERT cells in 6-well 256"
plates were pre-chilled on ice before being infected with 200 pfu of HSV1 per well, and the 257"
infections were maintained on ice to allow binding of virus particles without penetration. 258"
After each time point, the inoculum was removed and any unbound virus was washed 259"
away before fresh media was added to the cells that were incubated for 3 days before 260"
fixing and staining. Resultant plaques were counted and the overall rate of adsorption 261"
calculated as the percentage of total adsorption at each time point, where the final plaque 262"
count at the 180 min time point on ice was considered 100% (Fig. 3A).  In this assay each 263"
resultant plaque that was counted stems from a single virus particle that had bound to a 264"
cell whilst on ice.  At 5 minutes after infection both Vero and nTERT cells had bound 265"
approximately 25% of total virus, and the subsequent rate of binding over the next 180 min 266"
was almost indistinguishable between the two cell types (Fig. 3A). Hence, both cell types 267"
support virus binding with similar characteristics. 268"
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We next measured the ability of HSV1 to enter nTERT cells using an adapted penetration 269"
assay (23, 27). This assay uses a low pH buffer to inactivate any bound or extracellular 270"
virus particles (28) allowing only virus that has penetrated the cell to be protected from the 271"
buffer treatment. To measure the relative efficiency of HSV1 entry into nTERT cells, both 272"
nTERT and Vero cells were pre-chilled and infected on ice with 200 plaque-forming units 273"
of HSV1 for 2 hours to allow maximal virus binding without penetration. The cells were 274"
then washed and overlaid with fresh, pre-warmed media and warmed to 37°C for 275"
increasing times to allow virus penetration to begin.  At the indicated times, the cells were 276"
treated with low pH buffer for one minute to inactivate any bound or extracellular virus 277"
particles, fresh media added, and cells incubated at 37°C for plaques to form. Comparison 278"
of the percentage protection at each time point, taking the final plaque count at 60 minutes 279"
as 100%, revealed a significant difference in the kinetics of HSV1 penetration into nTERT 280"
cells compared to Vero cells (Fig. 3B). In Vero cells the percentage of penetrated virus 281"
increased steadily until it plateaued at 100%, 50 minutes after warming (Fig. 3B, Vero).  By 282"
contrast, maximal penetration was reached in nTERT cells at just 5 minutes after warming, 283"
indicating that the kinetics of HSV1 entry into nTERT cells is much faster than Vero cells 284"
(Fig. 3B, nTERT).   285"
As the above comparison had been between a human and a monkey cell line, we wanted 286"
to ensure that the dramatic difference in entry rate was cell type specific rather than 287"
species specific. To this end, the above penetration assay was repeated, this time 288"
including the human primary fibroblast cell line HFFF2 (Fig. 3C).  In both Vero and nTERT 289"
cells the low pH protection rates were similar to that seen before (Fig. 3C). However, the 290"
percentage virus protection rate in HFFF2 cells was comparable to that of Vero cells rather 291"
than that in nTERT cells, with the protection rate increasing steadily and plateauing at 292"
around 50 min (Fig. 3C). Hence, these data confirm that the rapid virus protection rate 293"
identified in nTERT cells is unusual to keratinocyte cells.  294"
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HSV1 enters nTERT cells by rapid plasma membrane fusion. The penetration assay 295"
relies on virus becoming protected from low pH treatment by being internalised into the 296"
cell through penetration.  However, given the unexpected results described above, we 297"
used electron microscopy (EM) to examine the cell surface of nTERT cells and determine 298"
if there could by a physical explanation for the rapid protection of all virus particles. 299"
Vertical sections taken through Vero or nTERT cells fixed in situ revealed that nTERT cells 300"
have a very different cell surface profile, with multiple projections on their apical surface 301"
compared to the smooth surface of Vero cells (Fig. 4A). This characteristic cell surface 302"
was particularly evident when thicker sections were examined (Fig. 4B). We hypothesized 303"
that these protrusions may in some way be protecting non-penetrated virions from low pH 304"
disruption, thereby giving us a false high measurement of HSV1 penetration. Hence, we 305"
examined HSV1 infected nTERT cells by EM at 5 and 20 minutes after warming, to 306"
determine the location of virions. Monolayers of nTERT cells were infected on ice with 307"
gradient purified HSV1 at a multiplicity of 100, to allow maximal virus binding and to 308"
synchronise entry.  Cells were then shifted to 37°C for 5 or 20 minutes before immediately 309"
fixing on ice and processing for analysis by EM, being prepared either in horizontal or 310"
vertical sections (Fig. 5). Examination of the sections revealed the presence of intact virus 311"
particles on the surface of the infected keratinocytes (Fig. 5A). Of note, these virions were 312"
frequently localised at the base of cell projections, suggesting a preference for binding and 313"
entry at these sites.  Crucially, capsid profiles containing an electron dense granular core 314"
(nucleic acid) were readily detectable within the cell cytoplasm (Fig. 5B, C & D, arrowed).  315"
These profiles were most often identified near the plasma membrane and were always 316"
free in the cytosol, suggestive of entry by plasma membrane fusion. In some profiles, 317"
dense material could be seen on the underside of the plasma membrane between the 318"
membrane and the capsid, which is likely to be tegument proteins deposited after plasma 319"
membrane fusion (Fig. 5C, thick arrow). Of 100 internal capsids counted in the sample 320"
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fixed at 5 minutes, none were detected in vesicles iin the cytosol. This provides evidence 321"
that the majority of virus capsids had penetrated keratinocyte cells within 5 min by a route 322"
that is likely to involve plasma membrane fusion.  323"
HSV1 enters nTERT cells at low temperature. Previous studies have shown that low 324"
temperatures inhibit HSV1 entry into C10 murine melanoma cells (4), a result in 325"
agreement with the fact that endocytic uptake requires energy and hence is unable to 326"
occur at low temperatures (29). We wished to test the effect of low temperature on HSV1 327"
entry into nTERT keratinocytes, but to first identify temperatures where endocytosis was 328"
inhibited, we utilised Texas Red transferrin to monitor endocytic uptake of the transferrin 329"
receptor at different temperatures.  Vero and nTERT cells were pre-incubated at 37°C, 330"
21°C, 15°C, 7°C or 0°C, before being maintained at the same temperature for a further 30 331"
min incubation period in the presence of media containing Texas Red transferrin.  Cells 332"
were then washed of surface bound Texas Red transferrin, and fixed for analysis by 333"
fluorescence microscopy.  At 37°C, as expected, a robust Texas Red signal was detected 334"
as scattered punctate domains in the cytoplasm of both nTERT and Vero cells, reflecting 335"
transferrin uptake into recycling endosomes (Fig. 6, 37°C).  At 21°C this signal was greatly 336"
reduced but still detectable in the cytoplasm of both cell types (Fig. 6, 21°C). However at 337"
15°C very few punctate domains could be identified while the signal was absent from the 338"
7°C and 0°C samples (Fig. 6).  These results indicate that both Vero and nTERT cells lose 339"
the ability to endocytose Texas Red transferrin at low temperatures.  340"
To determine if HSV1 can enter either nTERT or Vero cells at the same temperatures 341"
tested for endocytosis, a modified version of the penetration assay was used where cells 342"
were infected on ice as before, but then shifted to a specific temperature for one hour 343"
before low pH treatment, with the number of plaques counted at 37°C taken to be 100%. 344"
No virus protection from low pH buffer treatment was seen after incubation for a further 345"
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hour on ice in either Vero or nTERT cells, in line with the known inability of virus to enter 346"
cells at this extreme temperature (Fig. 7A). Lowering of the entry temperature reduced 347"
entry into Vero cells by 80% at 21°C, by 90% at 15°C and by 100% at 7°C (Fig. 7A, Vero). 348"
By contrast, virus entry into nTERT cells was reduced by only 10% at 21°C and 25% at 349"
15°C (75%), while at 7°C, over 30% of bound virus survived the low pH treatment of the 350"
penetration assay (Fig. 7A, nTERT). Moreover, the same experiment carried out in the 351"
HaCaT keratinocyte cell line, revealed that this ability to initiate infection at low 352"
temperatures was not specific to nTERT keratinocytes, but seemed to be characteristic of 353"
human keratinocytes in general (Fig. 7A, HaCaT).  354"
To confirm true virus entry into nTERT cells at 7°C, EM analysis was carried out, revealing 355"
that profiles of naked capsids containing nucleic acid were readily detectable within the 356"
cell cytoplasm of cells infected at 7°C (Fig. 7B and C, thin arrows). This confirms that 357"
HSV1 is indeed able to penetrate keratinocytes at 7°C by plasma membrane fusion.  358"
Under these conditions, intracellular capsids were always observed at the cell periphery 359"
and often within cell surface protrusions, which were evident at this low temperature (Fig. 360"
7B to D). These images confirm that virus particles are able to enter the cytosol of 361"
keratinocytes, and are not merely protected on the extracellular surface after incubation at 362"
7°C. We conclude from these studies that HSV1 enters human keratinocytes by using the 363"
receptor nectin-1 to inititiate a rapid plasma membrane fusion pathway that occurs at low 364"
temperature, potentially providing an accurate reflection of conditions of virus infection in 365"
the human host  366"
REVISED MANUSCRIPT 
 18 
Discussion 367"
The first stage of any successful virus infection involves the entry of the virus into its target 368"
cell in the host.  Viruses have co-evolved with their hosts to exploit efficient routes of entry 369"
into cells and to target cell-types that provide a favourable environment for their 370"
propagation and subsequent transmission. In the case of HSV1, this route of entry 371"
involves the stratified epithelia that make up the epidermis of the skin or oral mucosa. 372"
These tissues are comprised mainly of keratinocytes and hence in its natural host, HSV1 373"
enters and replicates in the keratinocyte. Nonetheless, few studies have focused on how 374"
HSV1 enters or replicates in this cell type, while studies on other human or even animal 375"
cells have left an unclear picture for the exact mode of HSV1 entry into the cell. 376"
In this study we set about establishing how HSV1 enters a highly relevant model 377"
keratinocyte system, the nTERT cell. This cell line represents a tractable model that is 378"
nonetheless representative of primary keratinocytes, and has been used successfully for 379"
the study of other epitheliotropic viruses (18, 19). Importantly, these cells retain the ability 380"
to form stratified epithelia in the form of organotypic rafts in culture. Interestingly, we found 381"
that HSV1 replicates faster, and releases progeny earlier and in higher quantities in 382"
nTERT cells compared to Vero cells, suggesting that the virus is fine-tuned to the biology 383"
of the keratinocyte. Our study has revealed three important and novel aspects of HSV1 384"
entry into keratinocytes that serve to emphasize the importance of studying viruses in their 385"
relevant host cell. First, we have found that HSV1 enters with extreme rapidity, with over 386"
90% of virus inside cells within 5 minutes. Second and strikingly, we have shown that, 387"
unlike the case in other cells, HSV1 can enter keratinocytes at temperatures as low as 388"
7°C, with almost complete virus entry occurring as low as 21°C.  Third, and despite the 389"
fact that it is now generally accepted in the literature that HSV1 enters keratinocytes and 390"
many other cell types by endocytosis (3-6), entry at both 37°C and 7°C occurred by direct 391"
plasma membrane fusion. Although this is counter to current thinking, it is notable that 392"
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most studies on endocytosis of HSV1 have not involved human keratinocytes. In our 393"
hands, we found no evidence for endocytosis in any of the conditions that we studied, a 394"
fact that was confirmed by showing virus entry into these cells at temperatures in which 395"
both receptor-mediated endocytosis and macropincytosis are known to be inhibited (30, 396"
31), and where texas-red transferrin failed to be taken up into the cells. The only entry 397"
profiles observed in the conditions we examined were naked capsids located either 398"
directly beneath the plasma membrane or a short distance inside. It is important to note 399"
that in our ultrastructural analyses we have not scraped and pelleted cells prior to fixation 400"
for TEM, but have fixed, embedded and sectioned cells in situ, so that cells could be 401"
precisely oriented in relation to the plastic substrate of the dish in which they have been 402"
grown and infected. We suggest that because of the finger-like profile of the normal 403"
keratinocyte plasma membrane, cross-sectioning in an unknown orientation could result in 404"
virions caught in the extracellular space between these projections potentially appearing 405"
similar to virions trapped inside endocytic vesicles. Indeed, our results would fit with a 406"
recent, extensive study that showed that HSV1 entry into four different epithelial cell types 407"
did not require low pH conditions, endosomal maturation, dynamins, or clathrin- or 408"
caveolin- dependent uptake (8). These authors found that a dynamic actin cytoskeleton 409"
was the only requirement for virus entry, a feature that could be explained by either 410"
plasma membrane fusion or macropinocytosis. In our own experiments, we found that at 411"
7°C capsids were always found at the cell periphery, a result that likely reflects either an 412"
inability to progress through the cortical actin network, or the presence of an unstable 413"
microtubule network under these conditions, both of which would block inward transport of 414"
capsids to the nucleus and cause accumulation in the cytosol beneath the plasma 415"
membrane.  416"
Being an epitheliotropic virus that during primary infection infects its host at external sites 417"
of the body such as skin or lips, the ability of HSV1 to infect skin cells at temperatures 418"
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below core body temperature has physiological relevance. Indeed, studies have shown 419"
that the temperature of the skin can vary depending on the environmental conditions (32, 420"
33), with measurements of the skin varying from 14°C to 33°C depending on the external 421"
environment. HSV1 is not alone in its ability to infect cells at temperatures below human 422"
core – for example the alphavirus Sindbis virus, that is transmitted by mosquitoes, has 423"
been shown to infect BHK cells at 15°C (34, 35) while rhinoviruses infect preferentially at 424"
32°C – the temperature of the lining of the nose. (36). As the lipid composition of 425"
membranes dictates their fluidity at low temperature, it may be the case that keratinocyte 426"
membranes have evolved to function optimally at lower temperatures in the extremities of 427"
the body, and hence the ability for membranes to fuse would be retained in these 428"
conditions. In such a scenario, it is also possible that receptor clustering occurs in the 429"
keratinocyte but not the Vero cell membrane at low temperature, thereby facilitating 430"
efficient binding and fusion in these conditions. 431"
In addition to low temperature entry, the extreme rapidity of virus entry that we measured 432"
in both nTERT and HaCaT human keratinocytes was an unexpected result that requires 433"
further investigation. An obvious explanation would be the presence of a high 434"
concentration of receptor at the cell surface, and by the use of qPCR we have shown that 435"
both nectin-1 and HVEM mRNAs are expressed at high levels in nTERT cells, with over 436"
600 fold more HVEM mRNA in nTERT than HeLa cells. However, despite the high levels 437"
of HVEM, its depletion by siRNA had little effect on HSV1 entry. By contrast, siRNA 438"
depletion indicated that nectin-1 is the major entry receptor for HSV1 in nTERT cells. 439"
Although we cannot rule out a contribution of HVEM to HSV1 entry, the fact that nectin-1 440"
depletion reduced beta-galactosidase expression from an immediate early promoter to 441"
less than 10% of control cells implies that nectin-1 is indeed the preferred receptor for 442"
HSV1 in these cells. Moreover, this is also the scenario in HeLa cells where there is 60 443"
fold less nectin-1 mRNA present, suggesting that even low levels of nectin-1 can support 444"
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HSV1 entry. Together with our results on HeLa and nTERT cells presented here, nectin-1 445"
has now been shown to be the preferred entry receptor over HVEM in a range of different 446"
cell types (37-41). As such, it could be argued that the relatively high level of nectin-1 447"
expression in nTERT cells explains the rapid entry phenotype. However, we have also 448"
measured the nectin-1 mRNA level in the HaCaT keratinocyte cell type shown here to 449"
support rapid HSV1 entry in a similar fashion, and have found that they express around 450"
30-fold less nectin-1 than nTERT cells (data not shown). This suggests that there is more 451"
to the process of rapid HSV1 entry than simply a higher concentration of the relevant gD 452"
receptor. For instance, nectin-1 might form local high concentrations in specific cell surface 453"
microdomains, as has been suggested in other studies (9). In relation to this, although 454"
nectin-1 has been reported to be absent from lipid rafts in other cell types (42), virus gene 455"
expression was delayed in keratinocytes depleted of cholesterol (7). As such, further 456"
studies such as cholesterol depletion with cyclodextrans would be required to determine if 457"
lipid rafts play a role in virus entry into nTERT cells.  458"
Alternatively, despite not requiring HVEM for entry, the high concentration of HVEM in 459"
keratinocytes may facilitate rapid cell fusion by strengthening the virion interaction with the 460"
cell surface. Likewise, an additional co-receptor for one of the other fusion components 461"
may perform a similar function to increase the engagement of the fusion machinery with 462"
the plasma membrane. In light of this, we have demonstrated the presence of mRNA for 463"
the gB co-receptor pILRalpha inTERT cells at levels only slightly lower than in THP-1 464"
monocytes (data not shown).  Interestingly, another study has identified the innate immune 465"
scavenger receptor MARCO as a cellular factor that binds glycoprotein C and significantly 466"
enhances adsorption of HSV1 to keratinocytes (43). Although an attractive candidate for a 467"
keratinocyte co-receptor for HSV1 entry, our results here show that despite the vast 468"
difference in penetration rate between Vero and nTERT cells, there is no difference in the 469"
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ability of HSV1 to adsorb to either cell type, suggesting that MARCO-enhancement is 470"
unlikely to explain the difference in speed of entry into nTERT cells.  471"
Taken together, our findings provide new insights into the entry and replication of HSV1 in 472"
its physiologically relevant target cell, the human keratinocyte. The use of a naturally 473"
infected host cell rather than commonly available laboratory cell types has revealed that 474"
HSV1 uses an unusual plasma membrane fusion pathway that is likely to reflect the 475"
biology of the keratinocyte in its natural context – a pathway that now requires further 476"
investigation to understand its molecular features and identify new targets for antiviral 477"
intervention. Furthermore, as these cells retain the ability to form three-dimensional 478"
stratified epithelia representative of human skin, they provide us with a new and excellent 479"
model for HSV1 infection at its site of entry into the host. 480"
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Figure Legends 629"
Fig. 1: The nTERT keratinocyte cell line is permissive to HSV1 infection. (A) Confluent 630"
nTERT cell monolayers were infected with HSV1 (s17) at a multiplicity of two. Intracellular 631"
and extracellular virus was harvested at the times indicated and titrated onto Vero cells.  A 632"
representative of three independent experiments is shown as the mean, ± standard error 633"
of the data. (B & C) nTERT or Vero monolayers were infected with HSV1 (s17) at a 634"
multiplicity of two. Total virus was harvested at the times indicated and either titrated onto 635"
Vero cells (B) or processed for Western blots with antibodies against ICP0, ICP27, VP22, 636"
gD and α-tubulin as a loading control. (D) Vero and nTERT cells grown on coverslips were 637"
infected with HSV1 (s17) at a multiplicity of 2, fixed at the indicated times, and stained for 638"
immunofluorescence with an antibody to ICP0. Cells were imaged under a fluorescent 639"
microscope and the number of ICP0 positive cells per one hundred cells was scored. The 640"
mean ± standard error of the data from three independent experiments is shown, with data 641"
analysed by the Student’s t test .  642"
Fig. 2: HSV1 entry into nTERT cells requires the gD receptor nectin-1. (A & B) Nectin-1 643"
(A) or HVEM (B) mRNA was  quantitated in HeLa and nTERT cells by qRT-PCR using the 644"
ΔΔct method. The housekeeping gene RPLP0 was used to normalise expression of both 645"
genes. (C & D) nTERT or HeLa cells were reverse transfected with 30 nM nectin-1, HVEM 646"
or control siRNAs. Seventy-two hours later cells RNA was extracted from half of the siRNA 647"
transfected cells, and nectin-1 and HVEM mRNA levels quantitated by qRT-PCR using the 648"
ΔΔct method. The housekeeping gene RPLP0 was used to normalise expression of both 649"
genes (C).  The remaining cells were transferred in triplicate to 96-well plates and 650"
incubated for a further 16 hours. These cells were infected on ice with 110lacZ virus at a 651"
multiplicity of two for 1 hour prior to replacing the inoculum with fresh media at 37°C and 652"
incubating for a further 4 hours.  Cells were lysed and relative β-galactosidase activity 653"
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measured. A representative experiment is shown as the mean ± standard error of the data, 654"
relative to the negative siRNA control (D).   655"
Fig. 3: HSV1 enters nTERT cells more rapidly than Vero cells.  (A) Confluent layers of 656"
nTERT or Vero cells were infected with 200 plaque-forming units of HSV1 per well of a 6-657"
well plate on ice.  After the indicated time, the inoculum was removed and replaced with 658"
media containing 1% human serum.  The infection was allowed to develop for two days, 659"
when plaques were fixed, stained and counted. Data is represented as the percentage 660"
adsorption, where the final plaque count (at 180 min) is taken as 100%.  The mean and ± 661"
standard error of the data are given from one representative experiment (n=3).  (B) 662"
Confluent monolayers of nTERT or Vero cells were infected with 200 plaque-forming units 663"
of HSV1 per well of a 6-well plate on ice for two hours. The inoculum was removed and 664"
replaced with media at 37oC and incubated for the indicated times, before treatment with 665"
low pH buffer for 1 minute.  After treatment, cells were washed and overlaid with media 666"
containing 1% human serum.  The infection was allowed to continue for two days, when 667"
plaques were fixed, stained and counted. The mean and ± standard error of the data are 668"
given from one representative experiment (n>3).  Data is displayed as the percentage of 669"
virus protected at each time, where the final plaque count (at 60 min post warming) is 670"
taken as 100%. (C) Confluent monolayers of nTERT, Vero or HFFF2 cells were infected 671"
with 200 PFU of HSV1 and treated as in B. 672"
Fig. 4: nTERT keratinocytes exhibit multiple projections on their apical surfaces. Vero and 673"
nTERT cells were grown on plastic dishes before fixing and processing for TEM. After 674"
embedding the cell monolayer was sliced in the vertical axis to acquire slices from top to 675"
bottom of cells. Slices of 70 nm (A) or 500 nm (B) were analysed by TEM. Black arrows 676"
indicate where cell was attached to plastic dish (basal side of cell).  677"
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Fig. 5: HSV1 enters nTERT cells by rapid plasma membrane fusion. Monolayers of 678"
nTERT cells were pre-chilled on ice and infected with 100 PFU per cell of gradient purified 679"
HSV1 on ice for one hour. Cells were then shifted to 37°C for 5 min or 20 min before fixing 680"
on ice for TEM processing. Representative micrographs show (A) virions attached to cell 681"
surface; (B) capsids directly under plasma membrane; (C) tegument-like material 682"
deposited beside capsids; and (D) capsids deeper into the cytoplasm. Arrows indicate 683"
virions/capsids. Short arrows indicate possible tegument deposited under plasma 684"
membrane.  Scale bar = 200 nm.  685"
Fig. 6: Receptor mediated endocytosis of transferrin is inhibited at low temperatures.  686"
Monolayers of Vero and nTERT cells were incubated at indicated temperatures for 10 min 687"
before the media was replaced with media containing Texas Red-conjugated transferrin 688"
(2.5 µg/ml) at the same temperature for a further 30 min.  Cells were fixed in 4% 689"
paraformaldehyde and nuclei stained with DAPI (blue).  Images were acquired on a 690"
confocal Zeiss LSM510 META inverted laser-scanning microscope. Scale bar = 20 µm. 691"
Fig. 7: HSV1 enters keratinocyte cells at low temperatures.  (A) Confluent monolayers of 692"
nTERT, HaCaT or Vero cells were infected with 200 PFU of HSV1 per well of a 6-well 693"
plate on ice for one hour.  The inoculum was removed and replaced with media at the 694"
temperature indicated, and incubated at that temperature for 1 h before treatment with low 695"
pH buffer for 1 minute.  After treatment, cells were washed and overlaid with media 696"
containing 1% human serum.  The infection was allowed to continue for two days when 697"
plaques were fixed, stained and counted. The mean and ± standard error of the data are 698"
given from one representative experiment (n>3).  Data is displayed as the percentage of 699"
virus protected (% Protection) at each temperature, where the plaque count at 37°C was 700"
taken as 100%. (B to D) Monolayers of nTERT cells seeded in 60 mm dishes were pre-701"
chilled on ice and infected with 100 PFU per cell of gradient purified HSV1 on ice for one 702"
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hour.  Cells were then shifted to 7°C for 60 min before fixing on ice for TEM processing.  703"
Vertical sections were analysed and representative images are shown with arrows 704"
identifying intracellular capsids. Scale bar = 200 nm. 705"
 706"







